Aytu biopharma announces patent term extension for exxua(tm)

Denver, co / access newswire / october 28, 2025 / aytu biopharma, inc. (the "company" or "aytu") (nasdaq:aytu), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that the method of use patent (u.s. patent no. 7,538,116) for exxuatm (gepirone) extended-release tablets ("exxua") has been extended through september 2, 2030 under 35 u.s.c.
AYTU Ratings Summary
AYTU Quant Ranking